466 related articles for article (PubMed ID: 22118674)
1. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.
Altun M; Kramer HB; Willems LI; McDermott JL; Leach CA; Goldenberg SJ; Kumar KG; Konietzny R; Fischer R; Kogan E; Mackeen MM; McGouran J; Khoronenkova SV; Parsons JL; Dianov GL; Nicholson B; Kessler BM
Chem Biol; 2011 Nov; 18(11):1401-12. PubMed ID: 22118674
[TBL] [Abstract][Full Text] [Related]
2. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein.
Ali A; Raja R; Farooqui SR; Ahmad S; Banerjea AC
Biochem J; 2017 May; 474(10):1653-1668. PubMed ID: 28280111
[TBL] [Abstract][Full Text] [Related]
3. Proteomics of broad deubiquitylase inhibition unmasks redundant enzyme function to reveal substrates and assess enzyme specificity.
Rossio V; Paulo JA; Chick J; Brasher B; Gygi SP; King RW
Cell Chem Biol; 2021 Apr; 28(4):487-502.e5. PubMed ID: 33417828
[TBL] [Abstract][Full Text] [Related]
4. The small molecule inhibitor PR-619 of deubiquitinating enzymes affects the microtubule network and causes protein aggregate formation in neural cells: implications for neurodegenerative diseases.
Seiberlich V; Goldbaum O; Zhukareva V; Richter-Landsberg C
Biochim Biophys Acta; 2012 Nov; 1823(11):2057-68. PubMed ID: 22565157
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors.
Bushman JW; Donovan KA; Schauer NJ; Liu X; Hu W; Varca AC; Buhrlage SJ; Fischer ES
Cell Chem Biol; 2021 Jan; 28(1):78-87.e3. PubMed ID: 33007217
[TBL] [Abstract][Full Text] [Related]
6. USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.
Pozhidaeva A; Valles G; Wang F; Wu J; Sterner DE; Nguyen P; Weinstock J; Kumar KGS; Kanyo J; Wright D; Bezsonova I
Cell Chem Biol; 2017 Dec; 24(12):1501-1512.e5. PubMed ID: 29056420
[TBL] [Abstract][Full Text] [Related]
7. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
[TBL] [Abstract][Full Text] [Related]
8. USP7 substrates identified by proteomics analysis reveal the specificity of USP7.
Nie L; Wang C; Liu X; Teng H; Li S; Huang M; Feng X; Pei G; Hang Q; Zhao Z; Gan B; Ma L; Chen J
Genes Dev; 2022 Sep; 36(17-18):1016-1030. PubMed ID: 36302555
[TBL] [Abstract][Full Text] [Related]
9. Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.
Lamberto I; Liu X; Seo HS; Schauer NJ; Iacob RE; Hu W; Das D; Mikhailova T; Weisberg EL; Engen JR; Anderson KC; Chauhan D; Dhe-Paganon S; Buhrlage SJ
Cell Chem Biol; 2017 Dec; 24(12):1490-1500.e11. PubMed ID: 29056421
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response.
Perry JW; Ahmed M; Chang KO; Donato NJ; Showalter HD; Wobus CE
PLoS Pathog; 2012; 8(7):e1002783. PubMed ID: 22792064
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar A; Shibata E; Dutta A
Mol Cell Biol; 2013 Aug; 33(16):3309-20. PubMed ID: 23775119
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.
Wang Y; Jiang Y; Ding S; Li J; Song N; Ren Y; Hong D; Wu C; Li B; Wang F; He W; Wang J; Mei Z
Cell Res; 2018 Dec; 28(12):1186-1194. PubMed ID: 30254335
[TBL] [Abstract][Full Text] [Related]
13. USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth.
An T; Gong Y; Li X; Kong L; Ma P; Gong L; Zhu H; Yu C; Liu J; Zhou H; Mao B; Li Y
Biochem Pharmacol; 2017 May; 131():29-39. PubMed ID: 28216017
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors.
Chen C; Song J; Wang J; Xu C; Chen C; Gu W; Sun H; Wen X
Bioorg Med Chem Lett; 2017 Feb; 27(4):845-849. PubMed ID: 28108249
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes.
Setz C; Friedrich M; Rauch P; Fraedrich K; Matthaei A; Traxdorf M; Schubert U
Viruses; 2017 Aug; 9(8):. PubMed ID: 28805676
[TBL] [Abstract][Full Text] [Related]
16. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
Reverdy C; Conrath S; Lopez R; Planquette C; Atmanene C; Collura V; Harpon J; Battaglia V; Vivat V; Sippl W; Colland F
Chem Biol; 2012 Apr; 19(4):467-77. PubMed ID: 22520753
[TBL] [Abstract][Full Text] [Related]
17. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.
Zhang W; Sartori MA; Makhnevych T; Federowicz KE; Dong X; Liu L; Nim S; Dong A; Yang J; Li Y; Haddad D; Ernst A; Heerding D; Tong Y; Moffat J; Sidhu SS
J Mol Biol; 2017 Nov; 429(22):3546-3560. PubMed ID: 28587923
[TBL] [Abstract][Full Text] [Related]
18. Proteome changes induced by knock-down of the deubiquitylating enzyme HAUSP/USP7.
Kessler BM; Fortunati E; Melis M; Pals CE; Clevers H; Maurice MM
J Proteome Res; 2007 Nov; 6(11):4163-72. PubMed ID: 17927229
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic characterisation of USP7 deubiquitinating activity and inhibition.
Wrigley JD; Eckersley K; Hardern IM; Millard L; Walters M; Peters SW; Mott R; Nowak T; Ward RA; Simpson PB; Hudson K
Cell Biochem Biophys; 2011 Jun; 60(1-2):99-111. PubMed ID: 21468692
[TBL] [Abstract][Full Text] [Related]
20. Screening of DUB activity and specificity by MALDI-TOF mass spectrometry.
Ritorto MS; Ewan R; Perez-Oliva AB; Knebel A; Buhrlage SJ; Wightman M; Kelly SM; Wood NT; Virdee S; Gray NS; Morrice NA; Alessi DR; Trost M
Nat Commun; 2014 Aug; 5():4763. PubMed ID: 25159004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
